Serina Therapeutics, Inc. (SER): Total Liabilities
$6.99M
As of 2025-12-31
$7.08M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.99M | +12.4% | 2026-03-25, Balance as of period end |
| 2024-12-31 | $6.22M | +28.0% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $4.86M | n/c | 2025-03-24, Balance as of period end |
| 2022-12-31 | $20.56M | +36.8% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $15.03M | +61.2% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $9.32M | +93.2% | 2022-03-29, Balance as of period end |
| 2019-12-31 | $4.83M | +97.7% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $2.44M | +86.0% | 2020-03-31, Balance as of period end |
| 2017-12-31 | $1.31M | n/a | 2019-04-01, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.99M | +12.4% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $672.0K | +14.3% |
| iBio, Inc. (IBIO) | 2026-06-30 | $13.40M | +61.3% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $3.14M | -44.7% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $43.94M | -0.5% |
| Clene Inc. (CLNN) | 2025-12-31 | $35.72M | -1.3% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $1.30M | -45.3% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $6.56M | +21.9% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $50.21M | +12.4% |
Compare SER, BFRG, IBIO, LSTA side by side · Screen every company in Pharmaceutical Preparations ↗